AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Pretax margin (%)

Chiome Bioscience Inc.【JP:4583】

Market cap
¥7.4B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 2025-166.7+27.71%
Dec 31, 2024-130.5-26.81%
Dec 31, 2023-178.4-9.54%
Dec 31, 2022-197.2+5.75%
Dec 31, 2021-186.5-30.58%
Dec 31, 2020-268.6-14.76%
Dec 31, 2019-315.1-56.28%
Dec 31, 2018-720.7+111.97%
Dec 31, 2017-340-18.11%
Dec 31, 2016-415.2-7.25%
Dec 31, 2015-447.6-0.39%
Dec 31, 2014-449.4+162.48%
Mar 31, 2014-171.2+30.63%
Mar 31, 2013-131.1+1834.30%
Mar 31, 2012-6.8-86.78%
Mar 31, 2011-51.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)